FMD vaccine matching: inter laboratory study for improved understanding of r1 values

WILLEMS, TOM; LI, YANMIN; WILSDEN, GINETTE; MATTION, NORA; MARADEI, EDUARDO; DE CLERCQ, KRIS; PEREZ-FILGUEIRA, MARIANO; LEFEBVRE, DAVID; HAAS, BERND; BEASCOECHEA PEREZ, CLAUDIA; LA TORRE, JOSÉ; DE VLEESCHAUWER, ANNEBEL; LUDI, ANNA; STATHAM, BOB; ROBIOLO, BLANCA; SMITSAART, ELIANA

JOURNAL OF VIROLOGICAL METHODS

ELSEVIER SCIENCE BV

Año: 2020 vol. 276 p. 113786 - 113792

0166-0934

Foot-and-mouth disease virus (FMDV) is a highly variable RNA virus existing as seven different serotypes. The antigenic variability between and within serotypes can limit cross-reactivity and therefore the in vivo cross-protection of vaccines. The selection of appropriate vaccine strains is crucial in the control of FMD. Determination of indirect relationships (r1-value) between potential vaccine strains and field strains based on antibody responses against both are routinely used for vaccine matching purposes. Aiming at the investigation of the repeatability, reproducibility, and comparability of r1-value determination within and between laboratories and serological tests, a small scale vaccine matching ring test for FMDV serotype A was organized. Well-characterized serum pools from cattle vaccinated with a monovalent A24/Cruzeiro/Brazil/55(A24) FMD vaccine with known in vivo protection status (homologous and heterologous) were distributed to four laboratories to determine r1-values for the heterologous FMD strains A81/Argentina/87, A/Argentina/2000 and A/Argentina/2001 using the virus-neutralization tests (VNT) and liquid phase blocking ELISA (LPBE). Within laboratories, the repeatability of r1-value determination was high for both antibody assays. VNT resulted in reproducible and comparable r1-values between laboratories, indicative of a lack of antigenic relatedness between the A24 strain and the heterologous strains tested in this work, thus corresponding to some of the in vivo findings with these strains. Using LPBE, similar trends in r1-values were observed in all laboratories, but the overall reproducibility was lower than with VNT. Inconsistencies between laboratories may at least in part be attributed to differences in LPBE protocols as well as the in preexisting information generated in each laboratory (such as antibody titer-protection correlation curves).To gain more insight into the LPBE-derived r1-values standard bovine control sera were included in the antibody assays performed in each laboratory and a standardization exercise was performed.